A trial comparing the effect and safety of insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes.
Phase of Trial: Phase III
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Insulin aspart (Primary) ; Insulin degludec (Primary) ; Insulin detemir
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms EXPECT
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 17 Nov 2017 Planned number of patients changed from 189 to 300.
- 18 Sep 2017 New trial record